Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Beesley

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Molecular Genetics and Metabolism|August 7, 2019
Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in EnglandA Broomfield, J Davison, J Roberts, et al.
British Journal of Cancer|May 31, 2012
Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancerS Yao, S J Ireland, A Bee, et al.
Journal of Inherited Metabolic Disease|October 27, 2015
Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapyA Broomfield, J Fletcher, J Davison, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Molecular Genetics and Metabolism|August 7, 2019
Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in EnglandA Broomfield, J Davison, J Roberts, et al.
British Journal of Cancer|May 31, 2012
Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancerS Yao, S J Ireland, A Bee, et al.
Journal of Inherited Metabolic Disease|October 27, 2015
Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapyA Broomfield, J Fletcher, J Davison, et al.
Pageof 4